Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Cell Biology and Toxicology|June 5, 2003
A new hepatoma cell line for toxicity testing at repeated dosesN Fabre, E Arrivet, J Trancard, et al.
Cell Stress & Chaperones|June 1, 1997
Herpes simplex virus Us11 protein enhances recovery of protein synthesis and survival in heat shock treated HeLa cellsC Diaz-Latoud, J J Diaz, N Fabre-Jonca, et al.
Optics Express|January 26, 2011
Optimal design of a microcavity organic laser device under electrical pumpingM Chakaroun, A Coens, N Fabre, et al.
Revue Neurologique|May 2, 2002
[Influence of general practitioners' personal knowledge on migraine in medical attitudes towards their patients suffering from migraine]M Weber, J P Daurès, N Fabre, et al.
Differentiation; Research in Biological Diversity|September 24, 1998
The distribution of murine 115-kDa epithelial microtubule-associated protein (E-MAP-115) during embryogenesis and in adult organs suggests a role in epithelial polarization and differentiationN Fabre-Jonca, J M Allaman, G Radlgruber, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2015
Peripheral late reactivation of a previously typical monofocal Baló's concentric sclerosis lesionJ Pique, F Bonneville, D Brassat, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's diseaseO Rascol, U Sabatini, N Fabre, et al.
Veterinary Parasitology|April 19, 2011
Involvement of tannins and flavonoids in the in vitro effects of Newbouldia laevis and Zanthoxylum zanthoxyloïdes extracts on the exsheathment of third-stage infective larvae of gastrointestinal nematodesE V B Azando, M S Hounzangbé-Adoté, P A Olounladé, et al.
Revue Neurologique|October 8, 2014
An individual rehabilitation program: evaluation by Parkinsonian patients and their physiotherapistsF Ory Magne, N Fabre, C Gu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's diseaseO Rascol, N Fabre, O Blin, et al.
Pageof 7